Mellitus and Metabolic Syndrome

Moreover, the increased plasma NEFA concentration in NIDDM patients [40] provides substrate for VLDL production by the liver (see above), which is manifested as hypertriglyceridemia [41]. Thus, drugs with the potential of lowering NEFA levels 

---

Differential diagnoses include diabetes mellitus and metabolic syndrome because patients with these conditions share several similar characteristics with Cushing s syndrome patients (e.g., obesity, hypertension, hyperlipidemia, hyperglycemia, and insulin resistance). In women, the presentations of hirsutism, menstrual abnormalities, and insulin resistance are similar to those of polycystic ovary syndrome. Cushing s syndrome can be differentiated from these conditions by identifying the classic signs and symptoms of truncal obesity, "moon faces" with facial plethora, a "buffalo hump" and supraclavicular fat pads, red-purple skin striae, and proximal muscle weakness. 

Endocrine There was a high incidence of post-transplant diabetes mellitus and metabolic syndrome in 85 kidney transplant... 

---